312 related articles for article (PubMed ID: 19199349)
1. Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients: a systematic review and meta-analysis.
Sanghani M; Balk EM; Cady B
Cancer; 2009 Apr; 115(8):1613-20. PubMed ID: 19199349
[TBL] [Abstract][Full Text] [Related]
2. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
3. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
4. Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: a randomized clinical trial (INT09/98).
Agresti R; Martelli G; Sandri M; Tagliabue E; Carcangiu ML; Maugeri I; Pellitteri C; Ferraris C; Capri G; Moliterni A; Bianchi G; Mariani G; Trecate G; Lozza L; Langer M; Rampa M; Gennaro M; Greco M; Menard S; Pierotti MA
Cancer; 2014 Mar; 120(6):885-93. PubMed ID: 24323615
[TBL] [Abstract][Full Text] [Related]
5. Omission of axillary lymph node dissection for clinically node negative early-stage breast cancer patients.
Kobayashi R; Shiraishi K; Iwase S; Ohtomo K; Nakagawa K
Breast Cancer; 2015 Nov; 22(6):657-63. PubMed ID: 24756246
[TBL] [Abstract][Full Text] [Related]
6. Axillary node interventions in breast cancer: a systematic review.
Rao R; Euhus D; Mayo HG; Balch C
JAMA; 2013 Oct; 310(13):1385-94. PubMed ID: 24084924
[TBL] [Abstract][Full Text] [Related]
7. Surgical management of early stage invasive breast cancer: a practice guideline.
McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
[TBL] [Abstract][Full Text] [Related]
8. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.
Louis-Sylvestre C; Clough K; Asselain B; Vilcoq JR; Salmon RJ; Campana F; Fourquet A
J Clin Oncol; 2004 Jan; 22(1):97-101. PubMed ID: 14701770
[TBL] [Abstract][Full Text] [Related]
9. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.
; McGale P; Taylor C; Correa C; Cutter D; Duane F; Ewertz M; Gray R; Mannu G; Peto R; Whelan T; Wang Y; Wang Z; Darby S
Lancet; 2014 Jun; 383(9935):2127-35. PubMed ID: 24656685
[TBL] [Abstract][Full Text] [Related]
10. Comparing Observation, Axillary Radiotherapy, and Completion Axillary Lymph Node Dissection for Management of Axilla in Breast Cancer in Patients with Positive Sentinel Nodes: A Systematic Review.
Castelo M; Hu SY; Dossa F; Acuna SA; Scheer AS
Ann Surg Oncol; 2020 Aug; 27(8):2664-2676. PubMed ID: 32020394
[TBL] [Abstract][Full Text] [Related]
11. Complete axillary lymph node dissection for stage I-II carcinoma of the breast.
Danforth DN; Findlay PA; McDonald HD; Lippman ME; Reichert CM; d'Angelo T; Gorrell CR; Gerber NL; Lichter AS; Rosenberg SA
J Clin Oncol; 1986 May; 4(5):655-62. PubMed ID: 3701387
[TBL] [Abstract][Full Text] [Related]
12. Omission of axillary staging in elderly patients with early stage breast cancer impacts regional control but not survival: A systematic review and meta-analysis.
Liang S; Hallet J; Simpson JS; Tricco AC; Scheer AS
J Geriatr Oncol; 2017 Mar; 8(2):140-147. PubMed ID: 27986500
[TBL] [Abstract][Full Text] [Related]
13. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.
Ogiya A; Kimura K; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F; Iwase T
Breast Cancer; 2016 Mar; 23(2):318-22. PubMed ID: 25376341
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
15. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
[TBL] [Abstract][Full Text] [Related]
16. Primary axillary radiotherapy as axillary treatment in breast-conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes.
Hoebers FJ; Borger JH; Hart AA; Peterse JL; Th EJ; Lebesque JV
Cancer; 2000 Apr; 88(7):1633-42. PubMed ID: 10738222
[TBL] [Abstract][Full Text] [Related]
17. Axillary lymph node dissection versus sentinel lymph node biopsy alone for early breast cancer with sentinel node metastasis: A meta-analysis.
Li CZ; Zhang P; Li RW; Wu CT; Zhang XP; Zhu HC
Eur J Surg Oncol; 2015 Aug; 41(8):958-66. PubMed ID: 26054706
[TBL] [Abstract][Full Text] [Related]
18. "Axillary recurrences after sentinel lymph node biopsy: a multicentre analysis and follow-up of sentinel lymph node negative breast cancer patients".
van Wely BJ; van den Wildenberg FJ; Gobardhan P; van Dalen T; Borel Rinkes IH; Theunissen EB; Wijsman JH; Ernst M; van der Pol CC; Madsen EV; Vles WJ; Wauters CA; de Wilt JH; Strobbe LJ
Eur J Surg Oncol; 2012 Oct; 38(10):925-31. PubMed ID: 22633152
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
20. Pooled long-term outcomes from two randomized trials of axillary node sampling with axillary radiotherapy versus axillary node clearance in patients with operable node-positive breast cancer.
Bing AU; Kerr GR; Jack W; Chetty U; Williams LJ; Rodger A; Dixon JM
Br J Surg; 2016 Jan; 103(1):81-7. PubMed ID: 26768099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]